New agents in hepatocellular carcinoma.
Abou-Alfa
Ghassan K
GK
Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use
D020533:Angiogenesis Inhibitors; D000903:Antibiotics, Antineoplastic; D047428:Protein Kinase Inhibitors